Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bayer, Aronora in Preclinical Mfg. Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bayer, Aronora in Preclinical Mfg. Pact

Will manufacture AB-022 for the treatment of cardiovascular diseases

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bayer HealthCare and Aronora, Inc. have entered a strategic alliance to manufacture Aronora’s AB-022 compound for the treatment of cardiovascular diseases. As a tenant of the U.S. CoLaborator, Bayer’s life sciences incubator facility in San Francisco, Aronora, will partner with Bayer HealthCare’s Global Biologics Development group in Berkeley for the preclinical manufacture of AB-022. 
 
“We have established a close, trusted relationship with Bayer HealthCare,” said Andras Gruber, chief executive officer of Aronora.  “We are thrilled to extend our relationship with this agreement. The close proximity of Bayer’s research and manufacturing sites to the CoLaborator has made this partnership a natural fit for us. The in-depth drug discovery and manufacturing expertise at Bayer has been valuable for advancing our compound towards the clinic.”
 
“This partnership with Aronora highlights Bayer’s unique Bay Area footprint spanning from early stage research through development and manufacturing. We are proud to offer our partners access to Bayer’s experts across the entire drug development process,” said Chris Haskell, head of Bayer’s U.S. Science Hub. “Our partnering strategy is designed to be flexible, to meet the needs of our collaborators—including start-ups like Aronora. We are excited to advance this collaboration to share our manufacturing expertise and capabilities.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics